GYRE compared with YMT: revenue, margins and what each company keeps, and the suppliers and customers both name

GYREGyre Therapeutics, Inc.

Mkt capRevenueRevenue

YMTYimutian Inc.

Mkt capRevenueRevenue

Compare

GYREGyre Therapeutics, Inc.

YMTYimutian Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GYRE 4

—Jiangsu Wangao Pharmaceuticalsunlistedsupplier

—Nanjing Healthnice Pharmaceutical Technologyunlistedsupplier

—WuXi STAunlistedsupplier

—GNIunlistedsupplier

Shared 0

No disclosed counterparties: YMT.

Only YMT 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

GYREGyre Therapeutics, Inc.

4.75▲+18.58%· post 4.75

Mkt cap$548.9MRevenue$33MQ3 FY26Revenue$120MFY25

YMTYimutian Inc.

0.26▲+2.53%· post 0.27

ClosedNov 6 '26

Mkt cap$22.3MRevenue—Revenue—

Compare

ClosedNov 6 '26

GYREGyre Therapeutics, Inc.

YMTYimutian Inc.

4.75▲+18.58%post 4.75

Price

0.26▲+2.53%post 0.27

$548.9M

Mkt cap

$22.3M

Q3 FY26$33M

Revenue

—

FY25$120M

Revenue

—

GYRE4.75▲+18.58%vsYMT0.26▲+2.53%ClosedNov 6 '26